Oxidative damage and fibrogenesis

Free Radical Biology and Medicine

Volumn 22, Issue 1-2, 1997, Pages 287-305

  Poli, Giuseppe ^a   Parola, Maurizio ^a  

^a Ctro Interuniversitario F   (Italy)

Author keywords

4 Hydroxynonenal; Chronic diseases; Collagen deposition; Fibrogenesis; Fibrogenic cytokines; Free radicals; Hepatic stellate cells; Lipid peroxidation; Macrophages; Myofibroblast like cells; Oxidative stress; Reactive oxygen species; Sclerosis; Transforming growth factor beta

Indexed keywords

4 HYDROXYNONENAL; COLLAGEN; FREE RADICAL; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA;

AEROBIC METABOLISM; CHRONIC DISEASE; CONNECTIVE TISSUE; FIBROGENESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; LIPID PEROXIDATION; LIVER CELL; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SCLEROSIS;

EID: 0029859861     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(96)00327-9     Document Type: Article

References (219)

1. Slater T. F. Free radical mechanisms in tissue injury. 1972;Pion Ltd, London.
2. Slater T. F. Free radical mechanisms in tissue injury. Biochem. J. 222:1994;1-15.
3. Sies H. Oxidative stress. 1985;Academic Press, Orlando.
4. Poli G., Albano E., Dianzani M. U. The role of lipid peroxidation in liver damage. Chem. Phys. Lipids. 45:1987;117-142.
5. Orrenius S. Mechanisms of oxidative cell damage. Poli G., Albano E., Dianzani M. U. Free radicals: From basic science to medicine. 1992;47-64 Birkhauser Verlag, Basel.
6. Kass G. E. N., Duddy S. K., Orrenius S. Activation of hepatocyte protein kinase C by redox-cycling quinones. Biochem. J. 260:1989;499-507.
7. 4-induced oxidative stress. Biochem. Biophys. Res. Commun. 194:1993;635-641.
8. Murrell A. C., Francis J. O., Bromley L. Modulation of fibroblast proliferation by oxygen free radicals. Biochem. J. 265:1990;659-665.
9. Dianzani M. U. Lipid peroxidation and cancer. Crit. Rev. Oncol. Hematol. 15:1993;125-147.
10. Esterbauer H., Schaur R. J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11:1991;81-128.
11. Halliwell B., Gutteridge J. M., Cross C. E. Free radicals, antioxidants, and human disease: where are we now? J. Lab. Clin. Med. 119:1992;598-620.
12. Bissell D. M., Friedman S. L., Maher J. J., Roll F. J. Connective tissue biology and hepatic fibrosis: Report of a conference. Hepatology. 11:1990;488-498.
13. Gressner A. M. Liver fibrosis: Perspectives in pathobiochemical research and clinical outlook. Eur. J. Clin. Chem. Clin. Biochem. 29:1991;293-311.
14. Gressner A. M. Activation of proteoglycan synthesis in injured liver - A brief review of molecular and cellular aspects. Eur. J. Clin. Chem. Clin. Biochem. 32:1994;225-237.
15. Inuzuka S., Ueno T., Tanikawa K. Fibrogenesis in acute liver injuries. Pathol. Res. Pract. 190:1994;903-909.
16. Pinzani M. Novel insights into the biology and physiology of the Ito cell. Pharmacol. Ther. 66:1995;387-412.
17. Friedman S. L. Gene expression of cytokine receptors during lipocyte (fat-storing cells) activation. Surrenti C., Casini A., Milani S., Pinzani M., Fat-storing cells and liver fibrosis. 1994;236-240 Kluwer, Dordrecht.
18. 4-induced liver cirrhosis by silymarin. Fundam. Clin. Pharmacol. 3:1989;183-191.
19. Parola M., Leonarduzzi G., Biasi F., Albano E., Biocca M. E., Poli G., Dianzani M. U. Vitamin E dietary supplementation protects against carbon tetrachloride-induced chronic liver damage and cirrhosis. Hepatology. 16:1992;1014-1021.
20. Parola M., Muraca R., Dianzani I., Barrera G., Leonarduzzi G., Bendinelli P., Piccoletti R., Poli G. Vitamin E dietary supplementation inhibits transforming growth factor β1 gene expression in the rat liver. FEBS Lett. 308:1992;267-270.
21. Pierce R. A., Glaug M. R., Greco R. S., Mackenzie J. W., Boyd C. D., Deak S. B. Increased procollagen mRNA levels in carbon tetrachloride-induced liver fibrosis in rat. J. Biol. Chem. 262:1987;1652-1658.
22. Armendariz-Borunda J., Seyer J. M., Kang A. H., Raghow R. Regulation of TGFbeta gene expression in rat liver intoxicated with carbon tetrachloride. FASEB J. 4:1990;215-221.
23. Miao S, Bao-En W., Annoni G., Degli Esposti S., Biempica L., Zern M. A. Two rat models of hepatic fibrosis. A morphological and molecular comparison. Lab. Invest. 63:1990;467-475.
24. Bedossa P., Houglum K., Trautwein C., Holstege A., Chojkier M. Stimulation of collagen alpha1(I) gene expression is associated with lipid peroxidation in hepatocellular injury: A link to tissue fibrosis? Hepatology. 19:1994;1262-1271.
25. Tsukamoto H., French S. W. Insights into the pathogenesis of alcoholic liver necrosis and fibrosis: Status report. Hepatology. 12:1990;599-608.
26. Nordmann R., Ribière C., Rouach H. Implication of free radical mechanisms in ethanol-induced cellular injury. Free Radic. Biol. Med. 12:1992;219-240.
27. Albano E., Clot P., Tabone M., Aricò S., Ingelman-Sundberg M. Oxidative damage and human alcoholic liver disease. Experimental and clinical evidence. Poli G., Albano E., Dianzani M. U. Free radicals: From basic science to medicine. 1993;310-322 Birkhauser Verlag, Basel.
28. Tsukamoto H. Oxidative stress, antioxidants, and alcoholic liver fibrogenesis. Alcohol. 10:1993;465-467.
29. Ingelman-Sundberg M. Ethanol-inducible cytochrome P-450 2E1. Regulation, radical formation and toxicological importance. Poli G., Albano E., Dianzani M. U. Free radicals: From basic science to medicine. 1993;287-301 Birkhauser Verlag, Basel.
30. Lieber C. S. Alcohol and the liver: 1994 update. Gastroenterology. 106:1994;1085-1105.
31. Kamimura S., Gaal K., Britton R. S., Bacon B. R., Triadafilopoulos G., Tsukamoto H. Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: Association of lipid peroxidation with liver fibrogenesis. Hepatology. 16:1992;448-453.
32. French S. W., Wong K., Albano E., Hagbjork A. L., Ingelman-Sundberg M. Effect of ethanol on cytochrome P450 2E1 (CYP2E1), lipid peroxidation, and serum protein adduct formation in relation to liver pathology pathogenesis. Exp. Mol. Pathol. 58:1993;61-75.
33. Tsukamoto H., Horne W., Kamimura S., Niemela O., Parkkila S., Yla-Herttuala S., Brittenham G. M. Experimental liver cirrhosis induced by alcohol and iron. J. Clin. Invest. 96:1995;620-630.
34. Lemonnier F., Cresteil D., Feneant M., Couturier M., Bernard O., Alagille D. Plasma lipid peroxides in cholestatic children. Acta Pediatr. Scand. 76:1987;928-934.
35. Lubrano R., Frediani T., Citti G., Cardi E., Mannarino O., Elli M., Cozzi F. Erythrocyte membrane lipid peroxidation before and after vitamin E supplementation in children with cholestasis. J. Pediatr. 115:1989;380-384.
36. Sokol R. J., Heubi J. E., McGraw C., Balistreri W. F. Correction of vitamin E deficiency in children with chronic cholestasis. II. Effects on gastrointestinal and hepatic function. Hepatology. 6:1986;1263-1269.
37. Desmet V. J. Cholestasis: Extrahepatic obstruction and secondary biliary cirrhosis. MacSween R. N. M., Anthony P. P., Scheuer P. J. Pathology of the liver. 2nd edition:1987;364-427 Churchill Livingstone, Edinburgh.
38. Parola M., Leonarduzzi G., Robino G., Albano E., Poli G., Dianzani M. U. On the role of lipid peroxidation in the pathogenesis of liver damage induced by long-standing cholestasis. Free Radic. Biol. Med. 20:1996;351-359.
39. Singh S., Shackleton G., Ah-Singh E., Chakraborty J., Bailey M. E. Antioxidant defenses in the bile duct-ligated rat. Gastroenterology. 103:1992;1625-1629.
40. Panozzo M. P., Basso D., Balint L., Biasin M. R., Bonvicini P., Metus P., Plebani M. Altered lipid peroxidation glutathione ratio in experimental extrahepatic cholestasis. Clin. Exp. Pharmacol. Physiol. 22:1995;266-271.
41. Muriel P., Suarez O. R. Role of lipid peroxidation in biliary obstruction in the rat. J. Appl. Toxicol. 14:1995;423-426.
42. Krahenbuhl S., Talos C., Lauterburg B. H., Reichen J. Reduced antioxidative capacity in liver mitochondria from bile duct ligated rats. Hepatology. 22:1995;607-612.
43. Sokol R. J., Deveraux M., Khandwala R. A. Effect of dietary lipids and vitamin E on mitochondrial lipid peroxidation and hepatic injury in the bile duct-ligated rat. J. Lipid Res. 32:1991;1349-1357.
44. Sokol R. J., Devereaux M., Khandwala R., O'Brien K. Evidence for involvement of oxygen free radicals in bile acid cytotoxicity to isolated rat hepatocytes. Hepatology. 17:1993;869-881.
45. Sokol R. J., Winklhofer-Roob B. M., Devereaux M. W., McKim J. M. Jr. Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids. Gastroenterology. 109:1995;1249-1256.
46. Dahm L. J., Hewett J. A., Roth R. A. Bile and bile salts potentiate superoxide anion release from activated rat peritoneal neutrophils. Toxicol. Appl. Pharmacol. 95:1988;82-92.
47. Hines J. E., Johnson S., Burt A. D. In vivo response of macrophages and perisinusoidal cells to cholestatic liver injury. Am. J. Pathol. 142:1993;511-518.
48. Simon M., Bourel L., Genetet B., Fauchet R. Idiopathic hemochromatosis: Demonstration of recessive transmission and early detection by family HLA typing. N. Engl. J. Med. 297:1977;1017-1022.
49. Bacon B. R., Britton R. S. The pathology of hepatic iron overload: A free radical-mediated process? Hepatology. 11:1990;127-137.
50. Bassett M. L., Halliday J. W., Powell L. W. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis. Hepatology. 6:1986;24-29.
51. Gutteridge J. M. C., Rowley D. A., Griffiths E., Halliwell B. Low-molecular-weight iron complexes and oxygen radical reactions in idiopathic hemochromatosis. Clin. Sci. 68:1985;463-467.
52. Bonkovsky H. L. Iron and the liver. Am. J. Med. Sci. 301:1991;32-43.
53. Britton R. S., Bacon B. R. Role of free radicals in liver diseases and hepatic fibrosis. Hepatogastroenterology. 41:1994;343-348.
54. Peters S. W., Jones B. M., Jacobs A., Wagstaff M. Free iron and lipid peroxidation in the plasma of patients with iron overload. Spik G., Montreuil J., Chricton R. R., Mazurier J. Proteins of iron storage and transport. 1985;321-324 Elsevier Science Publ, New York.
55. Young I. S., Trouton T. G., Torney J. J., McMaster D., Callender M. E., Trimble E. R. Antioxidant status and lipid peroidation in hereditary haemochromatosis. Free Radic. Biol. Med. 16:1994;393-397.
56. Niemela O., Parkkila S., Britton R. S., Ramm G. A., O'Neill R., Janney C. G., Brunt E. M., Bacon B. R. Hepatic lipid peroxidation in patients with hereditary henochromatosis. Hepatology. 22:1995;372A. [Abstr.].
57. Pietrangelo A., Rocchi E., Schiaffonati L., Ventura E., Cairo G. Liver gene expression during chronic dietary iron overload in rats. Hepatology. 11:1990;798-804.
58. Pietrangelo A., Gualdi R., Casalgrandi G., Geerts A., De Bleser P., Montosi G., Ventura E. Enhanced hepatic collagen type I mRNA expression into fat-storing cells in a rodent model of hemochromatosis. Hepatology. 19:1994;714-721.
59. Ramm G. A., Li L., Britton R. S., O'Neill R., Kobayashi Y., Bacon B. R. Chronic iron overload causes activation of rat lipocytes in vivo. Am. J. Physiol. 268:1995;G451-G458.
60. Li L., O'Neill R., Brown K. E., Soweid A. M., Britton R. S., Poulos J. E., Bacon B. R. Vitamin E suppresses lipocyte activation in chronic iron overload. Hepatology. 22:1995;279A. [Abstr. 690.].
61. Pietrangelo A., Gualdi R., Casalgrandi G., Montosi G., Ventura E. Molecular and cellular aspects of iron-induced hepatic cirrhosis in rodents. J. Clin. Invest. 95:1995;1824-1831.
62. Sternlieb I. Copper and the liver. Gastroenterology. 78:1980;1615-1630.
63. Walshe J. M. Copper: Its role in the pathogenesis of liver disease. Semin. Liver Dis. 4:1984;252-263.
64. Wu J., Forbes J. R., Chen H. S., Cox D. W. The LEC rat has a deletion in the copper transporting ATPase gene homologous to the Wilson disease gene. Nature Genet. 7:1994;541-545.
65. Sternlieb I. Perspectives on Wilson's disease. Hepatology. 12:1990;1234-1239.
66. Sokol R. J., Twedt D., McKim J. M. Jr., Deveraux M. W., Karrer F. M., Kam I., von Steigman G., Narkewicz M. R., Bacon B. R., Britton R. S., Neuschwander-Tetri B. A. Oxidant injury to hepatic mitochondria in patients with Wilson's disease and Bedlington terriers with copper toxicosis. Gastroenterology. 107:1994;1788-1798.
67. von Herbay A., de Groot H., Hegi U., Stremmel W., Strohmeyer G., Sies H. Low vitamin E content in plasma of patients with alcoholic liver disease, hemochromatosis and Wilson's disease. J. Hepatol. 20:1994;41-46.
68. Ogihara H., Ogihara T., Miki M., Yasuda H., Mino M. Plasma copper and antioxidant status in Wilson's disease. Pediatr. Res. 37:1995;219-226.
69. Sokol R. J., Devereaux M., Mierau G. W., Hambidge K. M., Shikes R. H. Oxidant injury to hepatic mitochondrial lipids in rats with dietary copper overload. Modification by vitamin E deficiency. Gastroenterology. 99:1990;1061-1071.
70. Sokol R. J., Devereaux M. W., O'Brien K., Khandwala R. A., Loehr J. P. Abnormal hepatic mitochondrial respiration and cytochrome c oxidase activity in rats with long-term copper overload. Gastroenterology. 105:1993;178-187.
71. Myers B. M., Prendergast F. G., Holman R., Kuntz S. M., LaRusso N. F. Alterations in hepatocyte lysosomes in experimental hepatic copper overload in rats. Gastroenterology. 105:1993;1814-1823.
72. Li L., Togashi Y., Sato S., Emoto T., Kang J. H., Takeichi N., Kobayashi H., Kojima Y., Une Y., Uchino J. Spontaneous hepatic copper accumulation in Long-Evans Cinnamon rats with hereditary hepatitis. A model of Wilson's disease. J. Clin. Invest. 87:1991;1858-1861.
73. Yamazaki K., Ohyama H., Kurata K., Wakabayashi T. Effects of dietary vitamin E on clinical course and plasma glutamic oxaloacetic transaminase and glutamic pyruvic transaminase activities in hereditary hepatitis of LEC rats. Lab. Anim. Sci. 43:1993;61-67.
74. Higueras V., Raya A., Rodrigo J. M., Serra M. A., Romà J., Romero F. J. Interferon decreases serum lipid peroxidation products of hepatitis C patients. Free Radic. Biol. Med. 16:1994;131-133.
75. Kikuyama M., Kobayashi Y., Kawasaki T., Yoshimi T. Hepatic lipid peroxidation in chronic hepatitis C. Hepatology. 22:1995;276A. [Abstr. 678.].
76. Zimmermann T., Franke H., Dargel R. Studies on lipid and lipoprotein metabolism in rat liver cirrhosis induced by different regimes of thioacetamide administration. Exp. Pathol. 30:1986;109-117.
77. Muller D., Sommer M., Kretzschmar M., Zimmermann T., Buko V., Lukivskaja O. J., Dargel R. Lipid peroxidation in thioacetamide-induced macronodular rat liver cirrhosis. Arch. Toxicol. 65:1991;199-203.
78. Heppleston A. G. Minerals, fibrosis, and the lung. Environ. Health Perspect. 94:1991;149-168.
79. Kamp D. W., Graceffa P., Pryor W. A., Weitzman S. A. The role of free radicals in asbestos-induced diseases. Free Radic. Biol. Med. 12:1992;293-315.
80. Janssen Y. M., Van Houten B., Borm P. J. A., Mossman B. T. Cell and tissue responses to oxidative damage. Lab. Invest. 69:1993;261-274.
81. Hodgson A. A. Chemistry and physics of asbestos. Michaels L., Chissick S. S. Asbestos. 1:1979;67-114 Wiley, New York.
82. Pooley F. D. Mineralogy of asbestos: The physical and chemical properties of the dusts they form. Semin. Oncol. 8:1981;243-249.
83. Halliwell B., Gutteridge J. M. C. Free radicals in biology and medicine. 1985;306-308 Clarendon Press, Oxford.
84. Halliwell B., Gutteridge J. M. C. Oxygen free radicals and iron in relation to biology and medicine: Some problems and concepts. Arch. Biochem. Biophys. 246:1986;501-514.
85. Aust S. D., Morehouse L. A., Thomas C. E. Role of metals in oxygen radical reactions. J. Free Radic. Biol. Med. 1:1985;3-25.
86. Zalma R., Bonneau L., Guignard J., Pezerat H. Formation of oxy-radicals by oxygen reduction arising from the surface activity of asbestos. Can. J. Chem. 65:1987;2238-2341.
87. Weitzmann S. A., Graceffa P. Asbestos catalyzes hydroxyl and superoxide radical generation from hydrogen peroxide. Arch. Biochem. Biophys. 228:1984;373-376.
88. Gulumian M., Van Wyk J. A. Hydroxyl radical production in the presence of fibres by a Fenton-type reaction. Chem. Biol. Interact. 62:1987;89-97.
89. Hansen K., Mossman B. T. Generation of superoxide from alveolar macrophages exposed to asbestiform and nonfibrous particles. Cancer Res. 47:1987;1681-1686.
90. Roney P. I., Holian A. Possible mechanism of chrysotile asbestos-stimulated superoxide anion production in guinea pig alveolar macrophages. Toxicol. Appl. Pharmacol. 100:1989;132-144.
91. Sesko A., Cabot M., Mossman B. T. Hydrolysis of inositol phospholipids precedes cellular proliferation in asbestos-stimulated tracheo-bronchial epithelial cells. Proc. Natl. Acad. Sci. USA. 87:1990;7385-7389.
92. Janssen Y. M., Marsh J. P., Driscoll K. E., Borm P. J., Oberdorster J., Mossman B. T. Increased expression of manganese-containing superoxide dismutase in rat lungs after inhalation of inflammatory and fibrogenic minerals. Free Radic. Biol. Med. 16:1994;315-322.
93. Cantin A., Dubois F., Begin R. Lung exposure to mineral dusts enhances the capacity of lung inflammatory cells to release superoxide. J. Leukocyte Biol. 43:1988;299-303.
94. Case B. W., Ip M. P. C., Padilla M., Kleinerman J. Asbestos effects on superoxide production: An in vitro study of hamster alveolar macrophages. Environ. Res. 39:1986;299-306.
95. Mossman B. T., Marsh J. P., Sesko A. Inhibition of lung injury, inflammation, and interstitial pulmonary fibrosis by polyethylene glycol-conjugated catalase in a rapid inhalation model of asbestosis. Am. Rev. Respir. Dis. 141:1990;1266-1271.
96. Petruska J. M., Leslie K. O., Mossman B. T. Enhanced lipid peroxidation in lung lavage of rats after inhalation of asbestos. Free Radic. Biol. Med. 11:1991;425-432.
97. Rom W., Harkin T. Dehydroepiandrosterone inhibits the spontaneous release of superoxide radicals by alveolar macrophages in vitro in asbestosis. Environ. Res. 55:1991;145-156.
98. Kamal A. A., el-Khafif M., Koraah S., Massoud A., Caillard J. F. Blood superoxide dismutase and plasma malondialdehyde among workers exposed to asbestos. Am. J. Ind. Med. 21:1992;353-361.
99. Giri S. N., Misra H. P., Chandler D. B., Chen Z. Increase in lung prolyl hydroxylase and superoxide dismutase activities during bleomycin-induced lung fibrosis in hamsters. Exp. Mol. Pathol. 39:1983;317-326.
100. Sugiura Y., Kikuchi T. Formation of superoxide and hydroxyl radicals in iron (II)-bleomycin-oxygen system: Electron spin resonance detection by spin trapping. J. Antibiot. 31:1978;1310-1312.
101. Sugiura Y., Suzuki T., Kuwahara J., Tanaka H. On the mechanism of hydrogen peroxide-, superoxide-, and ultraviolet light-induced DNA cleavages in inactive bleomycin-iron (III) complex. Biochem. Biophys. Res. Commun. 105:1982;1511-1518.
102. Hay J., Shahzeidi S., Laurent G. Mechanisms of bleomycin-induced lung damage. Arch. Toxicol. 65:1991;81-94.
103. Slosman D. O., Costabella P. M., Roth M., Werlen G., Polla B. S. Bleomycin primes monocytes-macrophages for superoxide production. Eur. Respir. J. 3:1990;772-778.
104. Parizada B., Werber M. M., Nimrod A. Protective effects of human recombinant MnSOD in adjuvant arthritis and bleomycin-induced lung fibrosis. Free Radic. Res. Commun. 15:1991;297-301.
105. Wang Q., Giri S. N., Hyde D. M., Li C. Amelioration of bleomycin-induced pulmonary fibrosis in hamsters by combined treatment with taurine and niacin. Biochem. Pharmacol. 42:1991;1115-1122.
106. Wang Q., Hyde D. M., Giri S. N. Abatement of bleomycin-induced increases in vascular permeability, inflammatory cell infiltration, and fibrotic lesions in hamster lungs by combined treatment with taurine and niacin. Lab. Invest. 67:1992;234-242.
107. Hoyt D. G., Lazo J. S. Acute pneumocyte injury, poly(ADP-ribose) polymerase activity, and pyridine nucleotide levels after in vitro exposure of murine lung slices to cyclophosphamide. Biochem. Pharmacol. 48:1994;1757-1765.
108. Vereckei A., Blazovics A., Gyorgy I., Feher E., Toth M., Szenasi G., Zsinka A., Foldiak G., Feher J. The role of free radicals in the pathogenesis of amiodarone toxicity. J. Cardiovasc. Electrophysiol. 4:1993;161-177.
109. Strauzs J., Muller-Quernheim J., Steppling H., Ferlinz R. Oxygen radical production by alveolar inflammatory cells in idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 141:1990;124-128.
110. Maier K., Leuschel L., Costabel U. Increased levels of oxidized methionine residues in bronchoalveolar lavage fluid proteins from patients with idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 143:1991;271-274.
111. Jack C. I., Jackson M. J. Circulating markers of free radical activity in patients with pulmonary tuberculosis. Tuberc. Lung Dis. 75:1994;132-137.
112. Buhl R., Vogelmeier C. Therapy of lung diseases with anti-oxidants. Pneumologie. 48:1994;50-56.
113. Sperra T. J., Collins F. S. The molecular basis of cystic fibrosis. Annu. Rev. Med. 44:1993;133-154.
114. Brown R. K., Kelly F. J. Role of free radicals in the pathogenesis of cystic fibrosis. Thorax. 49:1994;738-742.
115. Brown R. K., Kelly F. J. Evidence for increased oxidative damage in patients with cystic fibrosis. Pediatr. Res. 36:1994;487-493.
116. Langley S. C., Brown R. K., Kelly F. J. Reduced free radical-trapping capacity and altered plasma antioxidant status in cystic fibrosis. Pediatr. Res. 33:1993;247-250.
117. von Ruecker A. A., Bertele R., Harms H. K. Calcium metabolism and cystic fibrosis: Mitochondrial abnormalities suggest a modification of the mitochondrial membrane. Pediatr. Res. 18:1984;594-599.
118. Britigan B. E., Roeder T. L., Rasmussen G. T., Shasby D. M., McCormick M. L., Cox C. D. Interaction of the Pseudomonas aeruginosa secretory products pyocyanin and pyochelin generates hydroxyl radical and causes synergistic damage to endothelial cells. J. Clin. Invest. 90:1992;2187-2196.
119. Coffman T. J., Cox C. D., Edeker B. L., Britigan B. E. Possible role of bacterial siderophores in inflammation. Iron bound to the Pseudomonas siderophore pyochelin can function as a hydroxyl radical catalyst. J. Clin. Invest. 86:1990;1030-1037.
120. Evans P. H. Free radicals in brain metabolism and pathology. Br. Med. Bull. 49:1993;577-587.
121. Luft R. The development of mitochondrial medicine. Proc. Natl. Acad. Sci. USA. 91:1994;8731-8738.
122. Jenner P. Oxidative damage in neurodegenerative disease. Lancet. 344:1994;796-798.
123. Hall E. D., Braughler J. M. Free radicals in CNS injury. Waxman S. G. Molecular and cellular approaches to the treatment of neurological diseases. 1993;81-105 Raven Press, New York.
124. Adams J. D., Odunze I. N. Biochemical mechanisms of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity. Could oxidative stress be involved in the brain? Biochem. Pharmacol. 41:1991;1099-1105.
125. Griffin W. S. T., Stanley L. C., Ling C., White L., MacLeod V., Perrot L. J., White C. L., Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. Natl. Acad. Sci. USA. 86:1989;7611-7615.
126. Bauer J., Strauss S., Schreiter-Gasser U., Ganter U., Schlegel P., Witt I., Volk B., Berger M. Interleukin 6 and alpha2-macroglobulin indicate an acute phase state in Alzheimer's disease cortices. FEBS Lett. 285:1991;111-114.
127. Kaltschmidt B., Baeuerle P. A., Kaltschmidt C. Potential involvement of the transcription factor NF-kB in neurological disorders. Mol. Aspects Med. 14:1993;171-190.
128. Zagorski T., Dudek J., Brkan L., Mazurek M., Kedziora J., Chmielewski H. Superoxide dismutase (SOD-1) activity in erythrocytes of patients with multiple sclerosis. Neurol. Neurochir. Pol. 25:1991;725-730.
129. Langemann H., Kabiersch A., Newcombe J. Measurement of low molecular weight antioxidants, uric acid, tyrosine and tryptophan in plaques and white matter from patients with multiple sclerosis. Eur. Neurol. 32:1992;248-252.
130. Toshniwal P. K., Zarling E. J. Evidence for increased lipid peroxidation in multiple sclerosis. Neurochem. Res. 17:1992;205-207.
131. Korpela H., Kinnunen E., Juntunen J., Kumpulainen J., Koskenvuo M. Serum selenium concentration, glutathione peroxidase activity and lipid peroxides in a co-twin control study on multiple sclerosis. J. Neurol. Sci. 91:1989;79-84.
132. Rosen D. R., Siddique T., Patterson D., Figkewicz D. A., Sapp P., Hentati A., Donaldson D., Goto J., O'Regan J. P., Deng H.-X., Rahmani Z., Krizus A., McKenna-Yasek D., Cayabyab A., Gaston S. M., Berger R., Tanzi R. E., Halperin J. J., Herzfeldt B., Van den Bergh R., Hung W.-Y., Bird T., Deng G., Mulder D. W., Smyth C., Laing N. G., Soriano E., Pericak-Vance M. A., Haines J., Rouleau G. A., Gusella J. S., Horvitz H. R., Brown R. H. Jr. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62.
133. Andersen P. M., Nilsson P., Ala-Hurula V., Keranen M. L., Tarvainen I., Haltia T., Nilsson L., Binzer M., Forsgren L., Marklund S. L. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nature Genet. 10:1995;61-66.
134. Beckman J. S., Larson M., Smith C. D., Koppenol W. H. ALS, SOD and peroxynitrite. Nature. 364:1993;584.
135. Yim M. B., Boon Chock P., Stadtman E. R. Enzyme function of copper, zinc superoxide dismutase as a free radical generator. J. Biol. Chem. 268:1993;4099-4105.
136. Dal Canto M. C., Gurney M. E. Neuropathological changes in two lines of mice carrying a transgene for mutant Cu, Zn SOD, and in mice overexpressing wild type human SOD; a model of familial amyotrophic lateral sclerosis (FALS). Brain Res. 676:1995;25-40.
137. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature. 362:1993;801-809.
138. Palinski W., Rosenfeld M. E., Yla-Herttuala S., Gurtner G. C., Socher S. S., Butler S., Parthasarathy S., Carew T. E., Steinberg D., Witzum J. L. Low-density lipoprotein undergoes oxidative modification in vivo. Proc. Natl. Acad. Sci. USA. 86:1989;1372-1376.
139. Esterbauer H., Gebicki J., Puhl H., Jurgens G. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic. Biol. Med. 13:1992;341-390.
140. Morel D. W., Hessler J. R., Chisolm G. M. Low-density lipoprotein cytotoxicity induced by free radical peroxidation of lipids. J. Lipid Res. 24:1983;1070-1076.
141. Berliner J. A., Territo M., Sevanian A., Ramin S., Kim J. A., Ramshad B., Esterson M., Fogelman A. M. Minimally modified low-density lipoproteins stimulate monocyte endothelial interactions. J. Clin. Invest. 85:1990;1260-1266.
142. Fogelman A. M., Schechter I., Saeger J., Hokom M., Child J. S., Edwards P. A. Malonaldehyde alteration of low-density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc. Natl. Acad. Sci. USA. 77:1980;2214-2218.
143. Lavy A., Brook G. J., Danker G., Amotz A. B., Aviram M. Enhanced in vitro oxidation of plasma lipoproteins derived from hypercholesterolemic patients. Metabolism. 40:1991;794-799.
144. Maggi E., Marchesi E., Ravetta V., Falaschi F., Finardi G., Bellomo G. Low-density lipoprotein oxidation in essential hypertension. J. Hypertens. 11:1993;1103-1111.
145. Carew T. E., Schwenke D. C., Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: Evidence that antioxidants in vivo can selectively inhibit low-density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc. Natl. Acad. Sci. USA. 84:1987;7725-7729.
146. Rimm E. B., Stampfer M. J., Ascherio A., Giovannucci E., Colditz G. A., Willett W. C. Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 328:1993;1450-1456.
147. Boscoboinik D., Szewczyk A., Azzi A. α -Tocopherol (vitamin E) regulates vascular smooth muscle cell proliferation and protein kinase C activity. Arch. Biochem. Biophys. 286:1991;264-269.
148. Boscoboinik D., Chatelain E., Bartoli G. M., Stauble B., Azzi A. Inhibition of protein kinase C activity and vascular smooth muscle cell growth by d-alpha-tocopherol. Biochim. Biophys. Acta. 1224:1994;418-426.
149. Boscoboinik D., Ozer N. K., Moser U., Azzi A. Tocopherols and 6-hydroxy-chroman-2-carbonitrile derivatives inhibit smooth muscle cell proliferation by a non-antioxidant mechanism. Arch. Biochem. Biophys. 318:1995;241-246.
150. Crouch E. Pathobiology of pulmonary fibrosis. Am. J. Physiol. 259:1989;L159-L184.
151. Zhang K., Rekhter M. D., Gordon D., Phan S. H. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis. A combined immunohistochemical and in situ hydridization study. Am. J. Pathol. 145:1994;114-125.
152. Zhang K., Flanders K. C., Phan S. H. Cellular localization of transforming growth factor- β expression in bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 147:1995;352-361.
153. Khalil N., Bereznay O., Sporn M., Greenberg A. H. Macrophage production of transforming growth factor β and fibroblast collagen synthesis in chronic pulmonary inflammation. J. Exp. Med. 170:1989;727-737.
154. Broekelmann T. J., Limper A. H., Colby T. V., McDonald J. A. Transforming growth factor β1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis. Proc. Natl. Acad. Sci. USA. 88:1991;6642-6646.
155. Muller J. M., Ziegler-Heitbrock H. W. L., Baeuerle P. A. Nuclear factor kappa B, a mediator of lipolysaccharide effects. Immunobiology. 187:1993;233-256.
156. Nolan J. P. Intestinal endotoxins as mediators of hepatic injury. An idea whose time has come again. Hepatology. 10:1989;887-891.
157. Kuhn C., McDonald J. A. The roles of myofibroblast in idiopathic pulmonary fibrosis. Am. J. Pathol. 138:1991;1257-1265.
158. Burdon R. H. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic. Biol. Med. 18:1995;775-794.
159. Rao G. N., Berk B. C. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ. Res. 70:1992;593-599.
160. Rao G. N., Lassegue B., Griendling K. K., Alexander R. W., Berk B. C. Hydrogen peroxide-induced c-fos expression is mediated by arachidonic acid release: Role of protein kinase C. Nucleic Acids Res. 21:1993;1259-1263.
161. Rao G. N., Lassegue B., Griendling K. K., Alexander R. W. Hydrogen peroxide stimulates transcription of c-jun in vascular smooth muscle cells: Role of arachidonic acid. Oncogene. 3:1993;2759-2764.
162. ·- in vascular smooth muscle cells. Circ. Res. 77:1995;29-36.
163. Halliwell B., Aruoma O. I. DNA damage by oxygen-derived species: Its mechanism and measurement in mammalian systems. FEBS Lett. 281:1991;9-19.
164. Guyton K. Z., Kensler T. W. Oxidative mechanisms in carcinogenesis. Br. Med. Bull. 49:1993;523-544.
165. Breen A. P., Murphy J. A. Reaction of oxyl radicals with DNA. Free Radic. Biol. Med. 18:1995;1033-1077.
166. Godiard L., Grant M. R., Dietrich R. A., Kiedrowski S., Dangl J. L. Perception and response in plant disease. Curr. Opin. Genet. Dev. 4:1994;662-671.
167. Storz G., Tartaglia L. A., Ames B. N. Transcriptional regulator of oxidative stress-inducible genes: Direct activation by oxidation. Science. 248:1990;189-194.
168. Demple B. Regulation of bacterial oxidative stress genes. Annu. Rev. Genet. 25:1991;315-337.
169. Baeuerle P. A., Henkle T. Function and activation of NF-kB in the immune system. Annu. Rev. Immunol. 12:1994;141-179.
170. Toledano M. B., Leonard W. J. Modulation of transcription factor NF-kB binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. USA. 88:1991;4328-4332.
171. Grilli M., Chiu J. J. S., Lenardo M. J. NF-kB and Rel: Participants in a multiform transcriptional regulatory system. Int. Rev. Cytol. 143:1993;1-62.
172. Schreck R., Rieber P., Baeuerle P. A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kB transcription factor and HIV-1. EMBO J. 10:1991;2247-2258.
173. Angel P., Karin M. The role of Jun, Fos and the AP-1 complex in cell proliferation and transformation. Biochim. Biophys. Acta. 1072:1991;129-157.
174. Abate C., Patel L., Rauscher F. J., Curran T. Redox regulation of Fos and Jun DNA-binding activity in vitro. Science. 249:1990;1157-1161.
175. 2+-activated neutral protease in rat liver following carbon tetrachloride administration. Biochem. Biophys. Res. Commun. 197:1993;585-590.
176. Schreck R., Baeuerle P. A. NF-kappa B as inducible transcriptional activator of the granulocyte-macrophage colony-stimulating factor gene. Mol. Cell. Biol. 10:1990;1281-1286.
177. Messer G., Weiss E. H., Baeuerle P. A. Tumor necrosis factor beta (TNF-beta) induces binding of the NF-kappa B transcription factor to a high-affinity kappa B element in the TNF-beta promoter. Cytokine. 2:1990;1-9.
178. Libermann T. A., Baltimore D. Activation of the interleukin-6 gene expression through the NF-kappa B transcription factor. Mol. Cell. Biol. 10:1990;2327-2334.
179. Kim S. J., Dehnez F., Kim K. Y., Holt J. T., Sporn M. B., Roberts A. B. Activation of the second promoter of the transforming growth factor- β 1 gene by transforming growth factor- β 1 and phorbol ester occurs through the same target sequences. J. Biol. Chem. 264:1989;19373-19378.
180. Marra F., Choudhury G. G., Bhandari B., Abboud H. E. Biology and regulation of platelet-derived growth factor. Surrenti C., Casini A., Milani S., Pinzani M. Fat-storing cells and liver fibrosis. 1994;209-221 Kluwer Academic Publishers, London.
181. Dirks R. P. H., Jansen H. J., Gerritsma J., Onnekink C., Bloemers H. P. J. Localization and functional analysis of DNAase-I-hypersensitive sites in the human c-sis/PDGF-beta gene transcription unit and its flanking regions. Eur. J. Biochem. 11:1993;509-519.
182. Lin X., Wang Z., Gu L., Deuel T. F. Functional analysis of the human platelet-derived growth factor A-chain promoter region. J. Biol. Chem. 267:1992;25614-25619.
183. Meier M., Schreck R., Muller J. M., Bauerle P. A. Redox control of gene expression by eukaryotic transcription factors NF-kB, AP-1 and SRF/TCF. Pasquier C. Oxidative stress, cell activation and viral infection. 1994;217-235 Birkauser Verlag, Basel.
184. Datta R., Hallahan D. E., Kharbanda S. M., Rubin E., Sherman M. K., Humberman E., Weichselbaurm R. R., Kufe D. W. Involvement of reactive oxygen intermediates in the induction of c-jun gene transcription by ionising radiation. Biochemistry. 31:1992;8300-8306.
185. 6GG sequences to mediate activation of the early growth response 1 transcription factor gene by ionizing radiation. Proc. Natl. Acad. Sci. USA. 90:1993;2419-2422.
186. Kovacs E. J. Fibrogenic cytokines: The role of immune mediators in the development of scar tissue. Immunol. Today. 12:1991;17-23.
187. Ignotz R. A., Massagué J. Transforming growth factor- β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J. Biol. Chem. 261:1986;4337-4345.
188. Rossi P., Karsenty G., Roberts A. B., Roche N. S., Sporn M. B., de Crombrugghe B. A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta. Cell. 52:1988;405-414.
189. Edwards D. R., Murphy G., Reynolds J. J., Whitham S. E., Docherty A. J. P., Angel P., Heath J. K. Transforming growth factor beta modulates the expression of collagenase and metalloproteinase inhibitor. EMBO J. 6:1987;1899-1904.
190. Shull M. M., Ormsby I., Kier A. B., Pawlowski S., Diebold R. J., Yin M., Allen R., Sidman C., Proetzel G., Calvin D., Annunziata N., Doetschman T. Targeted disruption of the mouse transforming growth factor-beta1 gene results in multifocal inflammatory disease. Nature. 359:1992;693-699.
191. Kulkarni A. B., Karlsson S. Transforming growth factor beta-1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. Am. J. Pathol. 143:1993;3-9.
192. Poli G., Kinter A., Justement J. S., Kehrl J. H., Bressler P., Stanley S., Fauci A. S. Tumor necrosis factor α functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc. Natl. Acad. Sci. USA. 87:1990;782-785.
193. Pinzani M., Milani S., Grappone C., Weber F. L. Jr., Gentilini P., Abboud H. E. Expression of platelet-derived growth factor in a model of acute liver injury. Hepatology. 19:1994;701-707.
194. Chojkier M., Houglum K., Solis-Herruzo J., Brenner D. A. Stimulation of collagen gene expression by ascorbic acid in cultured human fibroblasts. A role for lipid peroxidation? J. Biol. Chem. 264:1989;16957-16962.
195. Houglum K., Brenner D. A., Chojkier M. d-Alpha-tocopherol inhibits collagen alpha 1(I) gene expression in cultured human fibroblasts. Modulation of constitutive collagen gene expression by lipid peroxidation. J. Clin. Invest. 87:1991;2230-2235.
196. Geesin J. C., Gordon J. S., Berg R. A. Retinoids affect collagen synthesis through inhibition of ascorbate-induced lipid peroxidation in cultured human dermal fibroblasts. Arch. Biochem. Biophys. 278:1990;350-355.
197. Geesin J. C., Hendricks L. J., Falkenstein P. A., Gordon J. S., Berg R. A. Regulation of collagen synthesis by ascorbic acid: Characterization of the role of ascorbate-stimulated lipid peroxidation. Arch. Biochem. Biophys. 290:1991;127-132.
198. Geesin J. C., Brown L. J., Gordon J. S., Berg R. A. Regulation of collagen synthesis in human dermal fibroblasts in contracted collagen gels by ascorbic acid, growth factors, and inhibitors of lipid peroxidation. Exp. Cell. Res. 206:1993;283-290.
199. 2+ in rat liver microsomes. Biochem. J. 208:1982;129-140.
200. Poli G., Dianzani M. U., Cheeseman K. H., Slater T. F., Lang J., Esterbauer H. Separation and characterization of the aldehydic products of lipid peroxidation stimulated by carbon tetrachloride and ADP-iron in isolated rat hepatocytes and rat liver microsomal suspensions. Biochem. J. 227:1985;629-638.
201. Parola M., Pinzani M., Casini A., Albano E., Poli G., Gentilini A., Gentilini P., Dianzani M. U. Stimulation of lipid peroxidation or 4-hydroxynonenal treatment increases procollagen alpha (I) gene expression and synthesis in human liver fat storing cells. Biochem. Biophys. Res. Commun. 194:1993;1044-1050.
202. Tsukamoto H. Activation of fat storing cells in alcoholic liver fibrosis: Role of Kupffer cells and lipid peroxidation. Surrenti C., Casini A., Milani S., Pinzani M. Fat storing cell and liver fibrosis. 1994;189-195 Kluwer Academic Publisher, Lancaster.
203. Beno D. W. A., Retsky J. E., Davis B. H. Lipid peroxidation-induced isoprostane independently activates Ito cell MAP kinase and increases type I collagen mRNA abundance. [Abstr. 776.] Hepatology. 20:1994;290A.
204. Maher J. J., Tzagarakis C., Gimenez A. Malondialdehyde stimulates collagen production by hepatic lipocytes only upon activation in primary culture. Alcohol & Alcoholism. 29:1994;605-610.
205. Lee K. S., Buck M., Houglum K., Chojkier M. Activation of hepatic stellate cells by TGFα and collagen type I is mediated by oxidative stress through c-myb expression. J. Clin. Invest. 96:1995;2461-2468.
206. Curzio M., Esterbauer H., Dianzani M. U. Chemotactic activity of hydroxyalkenals on rat neutrophils. Int. J. Tissue React. 7:1985;137-142.
207. Curzio M., Esterbauer H., Di Mauro C., Cecchini G., Dianzani M. U. Chemotactic activity of the lipid peroxidation product 4-hydroxynonenal and homologous aldehydes. Biol. Chem. Hoppe-Seyler. 367:1986;321-329.
208. Curzio M. Interaction between neutrophils and 4-hydroxyalkenals and consequences on neutrophil motility. Free Radic. Res. Commun. 5:1988;55-66.
209. Curzio M., Esterbauer H., Di Mauro C., Dianzani M. U. Influence of the lipid peroxidation product 4-hydroxynonenal on human neutrophil motility. Int. J. Tissue React. 6:1990;13-18.
210. Van Kuijk F. J. G. M., Thomas D. W., Stephens R. J., Dratz E. A. Occurrence of 4-hydroxyalkenals in rat tissues determined as pentafluorobenzyl oxime derivatives by gas chromatography-mass spectrometry. Biochem. Biophys. Res. Commun. 139:1986;144-149.
211. Curzio M., Esterbauer H., Poli G., Biasi F., Cecchini G., Di Mauro C., Cappello N., Dianzani M. U. Possible role of aldehydic lipid peroxidation products as chemoattractants. Int. J. Tissue React. 9:1987;295-306.
212. Curzio M., Poli G., Esterbauer H., Biasi F., Di Mauro C., Dianzani M. U. Detection of carbonyl products of lipid peroxidation in rat pleural exudate. IRCS Med. Sci. 14:1986;984-985.
213. Schaur R. J., Dussing G., Kink E., Schauenstein E., Posch W., Kukovetz E., Egger G. The lipid peroxidation product 4-hydroxynonenal is formed by - and is able to attract - rat neutrophils in vivo. Free Radic. Res. 20:1994;365-373.
214. Curzio M., Ferretti C., Stephens R. J., Esterbauer H., Dianzani M. U. Binding of the lipid peroxidation product 4-hydroxynonenal to human polymorphonuclear leukocytes. Cell Biochem. Funct. 12:1994;57-62.
215. Rossi M. A., Fidale F., Garramone A., Esterbauer H., Dianzani M. U. Effect of 4-hydroxyalkenals on hepatic phosphatidylinositol-4,5-biphosphate phospholipase C. Biochem. Pharmacol. 39:1990;1715-1719.
216. Stryer L., Bourne H. R. G-proteins - A family of signal transducers. Annu. Rev. Cell Biol. 2:1986;393-419.
217. Steinbrecher U. P. Oxidation of human low density lipoprotein results in derivatisation of lysine residues of apolipoprotein B by lipid peroxide decomposition products. J. Biol. Chem. 262:1987;3603-3608.
218. Cushing S. D., Berliner J. A., Valente A. J., Territo M. C., Navab M., Parhami F., Gerrity R., Schwartz C. J., Fogelman A. M. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. USA. 87:1990;5134-5138.
219. Rajavashisth T. B., Andalibi A., Territo M. C., Berliner J. A., Navab M., Fogelman A. M., Lusis A. J. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factor by modified low-density lipoproteins. Nature. 344:1990;254-257.